[Board of cardiovascular surgery in Japan: past, present, and future]

Haruo Makuuchi1

  • 1Department of Cardiovascular Surgery, St. Marianna University School of Medicine, Kawasaki, Japan.

Insights

The Japanese Board of Cardiovascular Surgery reforms aim to improve surgeon quality but may reduce numbers. Introducing physician assistants and medical coordinators can alleviate surgeon workload and improve the work environment.

Area of Science:

  • Cardiovascular Surgery
  • Surgical Education
  • Healthcare Workforce Management

Context:

  • The Japanese Board of Cardiovascular Surgery (JBCVS) was established in 2003 with enhanced certification criteria.
  • Recent reforms by the JBCVS aim to elevate the quality of board-certified cardiovascular surgeons.
  • The number of certified surgeons is projected to decline due to these stringent reforms.

Purpose:

  • To analyze the impact of JBCVS reforms on the cardiovascular surgery workforce in Japan.
  • To identify potential challenges and propose solutions for the future work environment of cardiovascular surgeons.
  • To address the anticipated decrease in surgeon numbers and its implications.

Summary:

  • The JBCVS has implemented stricter board certification criteria since 2003, focusing on improving surgeon quality.
  • Training hospital recognition will be limited from 2010, excluding those with low surgical volumes.
  • These measures are expected to significantly reduce the number of cardiovascular surgeons.

Impact:

  • The reforms may exacerbate the already challenging work environment for cardiovascular surgeons due to reduced numbers.
  • Implementing physician's assistant and medical coordinator systems is recommended to alleviate surgeon workload.
  • Addressing administrative burdens and postoperative care is crucial for retaining surgeons and ensuring quality patient care.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...